Introduction {#s1}
============

Dengue viruses (DENV) are the most important human arboviruses worldwide, transmitted by mosquitoes of the genus *Aedes*, *Aedes aegypti* is the main vector. Explosive epidemics have become a public health problem, economic impact, socially and politically significant [@pntd.0002095-Gubler1], [@pntd.0002095-Gubler2].

Currently it is estimated that 70 to 500 millions dengue infections occur annually in 124 endemic countries. Nearly 3.6 billion people (55% of world population) are at risk of contracting the disease (DVI). The rapid global spread of DENV in the last 50 years resulted in the dispersal of genotypes associated with increased severity [@pntd.0002095-Kyle1].

The four serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) are closely related yet antigenically distinct and contain a positive-sense RNA genome that is translated as a single polyprotein and post-translationally cleaved into three structural proteins, capsid (C), premembrane (prM) and envelope (E), and seven nonstructural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5. The RNA genome is packaged in an icosahedral capsid, and the nucleocapsid is surrounded by a lipid bilayer containing the E and M proteins [@pntd.0002095-Heinz1], [@pntd.0002095-Lindenbach1].

DENV infection causes a spectrum of clinical disease ranging from an acute debilitating, self-limited febrile illness - dengue fever (DF) - to a life-threatening syndrome - dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) [@pntd.0002095-WHO1]. Despite the similar disease manifestations, the DENV are genetically diverse with approximately 40% of amino acid sequence divergence. Distinct DENV genotypes can be characterized when the genetic divergence are higher than to 6% [@pntd.0002095-Twiddy1].

A recent analysis of 1,827 complete E gene sequences supported the existence of six genotypes for DENV-2: Asian genotype I, Asian genotype II, Southeast Asian/American genotype, Cosmopolitan genotype, American genotype and the Sylvatic genotype, the most genetically distinct genotype. Furthermore, the Southeast Asian/American genotype\'s topologies suggested a spatial division of this genotype into two major subclades [@pntd.0002095-Chen1].

In the Americas, the first DHF epidemics in the 80\'s were due to the introduction of the Southeast Asian/American genotype which replaced the American genotype and more severe cases with higher viremia were reported [@pntd.0002095-Lewis1]--[@pntd.0002095-RicoHesse1].

In Brazil, the disease has become a public health problem with explosive epidemics after the introduction of DENV-1 in 1986 in Rio de Janeiro [@pntd.0002095-Schatzmayr1]. However, the first DHF/DSS cases were only reported after the DENV-2 introduction in 1990 in the country [@pntd.0002095-Nogueira1], [@pntd.0002095-Nogueira2]. From 1990 until the 26th epidemiological week of 2010, a total of 5,481,921 cases, including 17,203 cases of dengue hemorrhagic fever (DHF) and 1954 deaths were reported in the country [@pntd.0002095-SVSMS1].

Aiming to perform the phylogeny of the DENV-2 and its impact in the disease severity during 20 years of viral activity in Brazil, strains isolated from DF, DHF/DSS and fatal cases occurred since its introduction in 1990 until 2010, were analyzed. In this scenario, the partial sequencing (C/prM/M/E genes) of 25 DENV-2 strains was performed. To determine whether the evolutionary relationships observed for the C/prM/M/E genes were applicable to the complete genome, we further fully sequenced the coding regions of nine DENV-2 strains. In order to avoid mutations introduced by *in vitro* passages of the virus in cell cultures we used DENV-2 strains extracted directly from serum or originally isolated from cell cultures.

Materials and Methods {#s2}
=====================

Ethical statement {#s2a}
-----------------

The strains analyzed in this study belong to a previously-gathered collection from the Laboratory of Flavivirus, IOC/FIOCRUZ, Rio de Janeiro, Brazil, obtained from human serum through the passive surveillance system performed by the Laboratory from an ongoing Project approved by resolution number CSN196/96 from the Oswaldo Cruz Foundation Ethical Committee in Research (CEP 274/05), Ministry of Health-Brazil. Samples were chosen anonymously, based on the laboratorial results and clinical manifestations input on the Laboratory database.

Viral strains {#s2b}
-------------

Viral strains consisted of DENV- 2 (*n* = 34) isolated during epidemics occurred from 1990 to 2010 in six states in Brazil ([Table 1](#pntd-0002095-t001){ref-type="table"}). Each sample was accompanied by identification form containing clinical and epidemiological data. All strains were determined as DENV-2 serotype by reverse transcriptase polymerase chain reaction (RT-PCR) and or/virus isolation from DF (*n* = 19), DHF (*n* = 3), DSS (*n* = 1) and fatal cases (*n* = 4; 1 from DF, 2 from DHF and 1 with no classification available). Seven cases were not classified due to data unavailability.

10.1371/journal.pntd.0002095.t001

###### Primers used for amplification of the partial and complete genes (coding region) from Brazilian DENV-2.

![](pntd.0002095.t001){#pntd-0002095-t001-1}

  Primers Designation            Sense A (5′→3′)                Anti-sense B (5′→3′)        Position in the genome (according to AF489932)   Amplicon (pb)   Tm (°C) A/B
  --------------------- ---------------------------------- ------------------------------- ------------------------------------------------ --------------- -------------
  1                         CGT GGA CCG ACA AAG ACA GA       GGA GCG ACG GCT GTC AGT AA                        14--906                            892           62/64
  2                         GAT CAG TGG CAC TCG TTC CA         CTC CGG GTAGCCATGGTAAC                         708--1586                           878           62/62
  3                         ATG GCA CTG TCA CGA TGG AG       CAC TAT CAG CCTGCACCATAGCT                       1467--2405                          938           62/63
  4                         GGA TCC CTG GGA GGA GTG TT       TCC ATT GCT CCA GAG GGT GT                       2202--3106                          904           63/63
  5                       GAC TCA AAA CTC ATG TCA GCG G      GTG CTT TGG GAA AGG AGT GC                       2958--3800                          842           62/62
  6                         GGG CGT TAC CAT GAC GGA T        GCC CAT GAT GGT TCA ATC CTT                      3656--4709                         1053           63/63
  7                         AAT TAC GGC AGC AGC ATG GT       GGA GGA GTG GCT GTC ATG AAA                      4475--5456                          981           63/63
  8                         CAG CCA TCA GAA CCG AGC A       CCA CCT TCT GTC TGC GTA GTT G                     5254--6185                          931           64/62
  9                      ACA CAC CTG AAG GAA TCA TTCCTA G    TGA CAA ATG TTG TAG CCA CGG                      6016--6948                          932           62/62
  10                        AGC CAT CCT CAC AGT GGT GG       TCT CAG TTT TGC TGA GCC TCG                      6791--7737                          946           64/63
  11                        CTA TTT GGC CGG AGC TGG A        TTT CAA TTC CAA TGT TGC GG                       7508--8354                          846           63/62
  12                     ATG GAG GAG CTT TAG TGA GGA ATC     CGT GCT CCA AGC CAC ATG TA                       8170--8994                          824           61/63
  13                        GAA ATC GGC TCG TGA GGC T        TCA TCT TGG TTT CTG CAT GGG                      8825--9746                          921           63/63
  14                     GAC AGT CAC AGA AGA AAT CGC TGT     CTA TGG CTT GAT CCG ACC TGA                     9473--10304                          831           62/62
  15                        CGG CTC ATT GAT TGG GCT AA       TTC TGT GCC TGG AAT GAT GCT                     10109--10662                         553           63/63

RNA extraction {#s2c}
--------------

Viral RNA was extracted from infected cell culture supernatant or directly from the patients\' serum using QIAamp Viral RNA Mini kit (Qiagen) following the manufacturer\'s instructions and stored at −70°C for DENV typing and sequencing.

RT --PCR (Reverse transcriptase- polymerase chain reaction) {#s2d}
-----------------------------------------------------------

RT---PCR for detecting and typing DENV was performed as described previously [@pntd.0002095-Lanciotti1]. Briefly, consensus primers were used to anneal to any of the four DENV types and amplify a 511-bp product in a reverse transcriptase-polymerase reaction. A cDNA copy of a portion of the viral genome was produced in a reverse transcriptase reaction. After a second round of amplification (nested PCR) with type-specific primers, DNA products of unique size for DENV-2 (119 bp) were generated.

Dengue virus isolation {#s2e}
----------------------

Virus isolation was performed by inoculation into C6/36 *Aedes albopictus* cell line [@pntd.0002095-Igarashi1] and isolates were identified by indirect fluorescent antibody test (IFAT) using serotype-specific monoclonal antibodies [@pntd.0002095-Gubler3]. Briefly, patients\' sera were inoculated into C6/36 *Aedes albopictus* cell monolayers in L-15 Medium (Leibovitz, Sigma) supplemented with 2% fetal calf serum (FCS, Invitrogen) and 0.2 mM of nonessential amino acids (Invitrogen). Cells were incubated at 28°C for 5 to 7 days and observed for cytopathic effects. Infected supernatant was clarified by centrifugation and virus stocks stored in 1-mL aliquots at −70°C until use.

Sequencing {#s2f}
----------

Reverse transcription (RT) was performed using 5 µL of extracted RNA in 25 µL of AccessQuick RT-PCR System (Promega Corporation) and specific oligonucleotides primers ([Table 1](#pntd-0002095-t001){ref-type="table"}). To amplify the C/prM/M/E region of 2,325 bp, specific primers (1 to 4) were used to produce 4 overlapping amplicons of approximately 900 bp and to amplify the complete coding region (10,173 bp), 15 overlapping amplicons of approximately 900 bp (1 to 15). Thermocycling conditions consisted of a single step of 42°C for 60 minutes and 40 cycles of denaturation at 94°C (30 seconds), annealing at 56°or 63°C (60 seconds) depending on the set of primers, extension at 72°C (2 minutes) and a final extension at 72°C (10 minutes). Amplification was conducted using a Model 9700 thermal cycler (Applied Biosystems). PCR products were purified from 1.0% agarose gels using QIAquick Gel extraction Kit or QIAquick PCR purification Kit (Qiagen) and used as template for cycle sequencing. Sequencing reactions were performed as recommended in the BigDye Dideoxy Terminator sequencing kit (Applied Biosystems) and the products were analyzed using an automated 3130 DNA Sequencer (Applied Biosystems). Partial sequences (C/prM/M/E) and complete coding sequences for the unprocessed polyprotein (5′ and 3′ noncoding regions excluded) were deposited in GenBank ([Table 2](#pntd-0002095-t002){ref-type="table"}).

10.1371/journal.pntd.0002095.t002

###### DENV-2 used in this study for partial (*n* = 25) and complete coding region (*n* = 9) sequencing.
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  Strain \#    Year of isolation             State of origin             Clinical manifestation   Imunne response     Age     Gender   Sequence region   Acess number GenBank
  ----------- ------------------- ------------------------------------- ------------------------ ----------------- --------- -------- ----------------- ----------------------
  44298              1991                          BA                              DF                    S            NA       Fem        C/prM/M/E            HQ012508
  48578              1994                          CE                              NA                   ND            NA       Male       C/prM/M/E            HQ012509
  51222              1995                          RJ                              NA                   ND            NA       Fem        C/prM/M/E            HQ012510
  52477              1995                          RJ                              NA                   ND            NA       Fem        C/prM/M/E            HQ012511
  55769              1996          RS[\*](#nt102){ref-type="table-fn"}             DF                   ND            10       Male       C/prM/M/E            HQ012512
  55803              1996                          BA                              NA                    S            NA       Fem        C/prM/M/E            HQ012513
  58448              1997                          RN                              DF                   ND            NA       Male       C/prM/M/E            HQ012514
  59382              1997                          RN                          DHF/Fatal                ND            NA       Male       C/prM/M/E            HQ012515
  63291              1998                          RJ                              DF                   ND            16       Male       C/prM/M/E            HQ012516
  64625              1999                          RJ                              DF                   ND            34       Male       C/prM/M/E            HQ012517
  66985              2000                          RJ                              DF                   ND            39       Male       C/prM/M/E            HQ012518
  67955              2000                          RJ                             DHF                   ND            27       Male       C/prM/M/E            HQ012519
  69221              2001                          RJ                              DF                   ND            28       Male       C/prM/M/E            HQ012520
  72308              2001                          RJ                              DF                   ND            62       Fem        C/prM/M/E            HQ012521
  75103              2002                          RJ                              DF                   ND            61       Masc       C/prM/M/E            HQ012522
  76012              2002                          ES                              NA                   ND            41       Fem        C/prM/M/E            HQ012523
  77395              2003                          ES                              NA                   ND            50       Male       C/prM/M/E            HQ012524
  86977              2007                          RJ                             DHF                   ND             7       Male       C/prM/M/E            HQ012525
  88034              2007                          RJ                              DF                   ND            12       Male       C/prM/M/E            HQ012526
  0030               2008                          RJ                              DF                    S            13       Male       C/prM/M/E            HQ012527
  0832               2008                          RJ                             DHF                    S             8       Fem        C/prM/M/E            HQ012528
  066                2009                          BA                              DF                   ND          1 month    Male       C/prM/M/E            HQ012529
  0145               2009                          ES                              DF                   ND            16       Male       C/prM/M/E            HQ012530
  023                2010                          RJ                              DF                   ND            73       Male       C/prM/M/E            HQ012531
  0199               2010                          RJ                             DSS                    S            50       Fem        C/prM/M/E            HQ012532
  39145              1990                          RJ                              DF                   ND            41       Fem       Complete CR           HQ012538
  41768              1990                          RJ                              DF                   ND            10       Male      Complete CR           HQ012533
  42727              1991                          RJ                              DF                    P            NI       Fem       Complete CR           HQ012534
  48622              1994                          CE                              NA                   ND            NI       Fem       Complete CR           HQ012535
  61310              1998                          RJ                              DF                   ND            47       Fem       Complete CR           HQ012536
  64905              1999                          RJ                              DF                   ND            52       Fem       Complete CR           HQ012537
  0337               2008                          RJ                            Fatal                   S          5 days      NA       Complete CR              NA
  0450               2008                          RJ                           DF/Fatal                 S            46       Male      Complete CR              NA
  0690               2008                          RJ                          DHF/Fatal                 S            32       Male      Complete CR           HQ026763

BA: Bahia, CE: Ceará, RJ: Rio de Janeiro, RS: Rio Grande do Sul, RN: Rio Grande do Norte, ES: Espírito Santo; DF: Dengue Fever; DHF: Dengue Hemorrhagic Fever; DSS: Dengue Shock Syndrome; Fem: Female; Male; C/prM/M/E: Capsid/pré-membrane/Membrane/Envelope; Complete CR: Complete coding region;

Imported case; NA: Not available; ND: Not done; P: primary infection; S: secondary infection.

Sequences and phylogenetic analysis {#s2g}
-----------------------------------

The analysis of similarities, percentage of identity and divergence among the strains analyzed were performed using Megalin Program (DNAstar, [www.dnastar.com](http://www.dnastar.com)). The multiple alignment was performed using CLUSTAL W (<http://www.ebi.ac.uk/clustalw/>) and the phylogenetic analysis by MEGA 4 software ([www.megasoftware.net](http://www.megasoftware.net)), using the Maximum Likelihood method (ML), according to the Tamura-Nei model, with a bootstrap of 1,000 replications. Strains representative from the five genotypes available in Genbank ([www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov)) were used for the comparison, DENV-1 (GenBank accession number GU370049), DENV-3 (accession number EF629369), and DENV- 4 (accession number AF289029) strains were used as outgroup to root the trees ([Table 3](#pntd-0002095-t003){ref-type="table"}).

10.1371/journal.pntd.0002095.t003

###### Strains representative of the different DENV-2 genotypes and strains used as outgroup for comparison purposes.
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  Strain \#                  Year of isolation        Country                   Genotype             GenBank Accession \#
  ------------------------- ------------------- -------------------- ------------------------------ ----------------------
  BR64022                          1998                Brazil          Southeast Asia (Lineage I)          AF489932
  BID-V3496                        1990              Venezuela         Southeast Asia (Lineage I)          GQ868540
  N.1409                           1983               Jamaica          Southeast Asia (Lineage I)           M20558
  BID-V2683                        1999              Nicaragua        Southeast Asia (Lineage II)          GQ199895
  BID-V2996                        2007              Nicaragua        Southeast Asia (Lineage II)          GQ199868
  BID-V595                         2006             Puerto Rico       Southeast Asia (Lineage II)          EU482726
  BID-V1439                        2005             Puerto Rico       Southeast Asia (Lineage II)          EU687216
  DR23/01                          2001          Dominican Republic   Southeast Asia (Lineage II)          AB122020
  DR59/01                          2001          Dominican Republic   Southeast Asia (Lineage II)          AB122022
  BID-V3653                        2008                Brazil         Southeast Asia (Lineage II))         GU131885
  China-04                         1985                China                    Asian II                   AF119661
  New Guinea C                     1944              New Guinea                 Asian II                   AF038403
  Strain 44                        1989                China                    Asian II                   AF204177
  TB16i                            2004              Indonesia                  Asian I                    AY858036
  98900666 DSS DV-2                1998              Indonesia                  Asian I                    AB189124
  IQT1797                          1995                 Peru                    American                   AF100467
  strain 131                       1992                Mexico                   American                   AF100469
  isolate 1328                     1977             Puerto Rico                 American                   EU056812
  Dak Ar D75505                    1991               Senegal                   Sylvatic                   EF457904
  DENV-1-SGEHI(D1)1494Y08          2008              Singapore                     \-                      GU370049
  BRDEN3 290-02                    2002                Brazil                      \-                      EF629369
  DENV-4-Guangzhou B5              2000                China                       \-                      AF289029

Results {#s3}
=======

In this study, the strains BR64022/98 isolated in the 90\'s and Jamaica 1983 were considered as reference strains for comparison purposes. The percentage of similarity among the 25 DENV-2 strains ranged from 80.3 to 99.9% when those compared to each other and to strains representative of the different genotypes available on GenBank. The partial genome sequencing analysis characterized the Brazilian DENV-2 strains from this study as belonging to the Southeast Asian genotype, however a distinction of two Lineages within this genotype has been identified. It was observed that strains circulating prior DENV-2 emergence (1990--2003) belong to Southeast Asian genotype, Lineage I and strains isolated after DENV-2 emergence in 2007 belong to Southeast Asian genotype, Lineage II ([Figures 1](#pntd-0002095-g001){ref-type="fig"} and [2](#pntd-0002095-g002){ref-type="fig"}). Furthermore, the latter were more closely related to strains from the Dominican Republic (DR59/01), representative from the Southeast Asian genotype, Lineage II.

![Maximum likelihood phylogeny based on the C/prM/M/E genes of 25 Brazilian DENV-2, 1991--2010.\
Black circles represent DENV-2 sequences generated in this study. Strains representative from the four genotypes available in Genbank ([www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov)) were used for the comparison, DENV-1, DENV-3 and DENV-4 strains were used as outgroup to root the trees. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. DENV strains used were named as follows: Country/strain number/state/year. RJ: Rio de Janeiro, ES: Espirito Santo, CE: Ceará, BA: Bahia, RS: Rio Grande do Sul, RN: Rio Grande do Norte.](pntd.0002095.g001){#pntd-0002095-g001}

![Maximum likelihood phylogeny based on the complete coding region sequencing of 9 Brazilian DENV-2, 1990--2008.\
Black circles represent DENV-2 sequences generated in this study. Strains representative from the four genotypes available in Genbank ([www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov)) were used for the comparison, DENV-1, DENV-3 and DENV-4 strains were used as outgroup to root the trees. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. DENV strains used were named as follows: Country/strain number/state/year. RJ: Rio de Janeiro and CE: Ceará.](pntd.0002095.g002){#pntd-0002095-g002}

When the 25 DENV-2 strains were compared to the strain BR64022/98, amino acid substitutions leading to change in the biochemical properties were observed on the C and prM genes. On the E gene, a total of twelve substitutions were observed, with nine resulting in a change on the amino acid change of biochemical property (Supplementary material 1). No consistent differences were observed on the E gene from strains isolated from cases with different clinical manifestations analyzed, suggesting that if the disease\'s severity has a genetic origin, it is not only due to the differences observed on the E gene.

To determine whether possible amino acids differences on other genes were related to disease severity, we fully analyzed (coding region) DENV-2 strains (*n* = 9), representative of DF cases isolated from 1990 to 1999 and strains isolated from fatal cases occurred after the DENV-2 re-emergence after 2007 until 2010. The strain 0450/2008, representative of the DENV-2 re-emergence isolated from a DF secondary case who evolved to death was fully sequenced and its comparison to the strain from the Dominican Republic (DR59/2001), representative of the DENV-2 re-emergence, showed 22 amino acid substitutions. Likewise, the strain 0690/2008 isolated from a DHF case occurred also during the re-emergence of DENV-2 had nine had amino acid substitutions when compared to the strain DR59/2001, with seven of those leading to amino acid biochemical property change ([Table S1](#pntd.0002095.s001){ref-type="supplementary-material"}).

The DENV-2 strain 0337/2008 isolated from a newborn presenting a high anti-DENV IgG titer who evolved to death, infected probably due transplacental transmission as his mother was diagnosed with acute DENV infection, showed substitutions on NS2A, NS4A and NS5, which were shared with the other two strains isolated from fatal cases ([Table S2](#pntd.0002095.s002){ref-type="supplementary-material"}). The results obtained by the DENV-2 full-length genome sequencing did not point out consistent differences related to a more severe disease.

A substitution on E~390~ (N→D) was reported as resulting in a reduction in viral replication in macrophages and dendritic cells [@pntd.0002095-Leitmeyer1] whereas E~390~ (D→N) resulted in enhanced replication, maturation and activation of macrophages, enhancement of the immune response with an increased production of cytokines, increased vascular permeability and consequently a greater chance of developing DHF [@pntd.0002095-Pryor1].All DENV-2 strains analyzed presented an asparagine (N) in E~390~, previously identified as a probable genetic marker of virulence observed in DHF strains from Asian origin.

The percentage of identity of the re-emergent DENV-2 with the Dominican Republic strain isolated in 2001 combined to the percentage of divergence with the strains first introduced in the country in the 90\'s suggests that those viruses did not evolved locally but were due to a new viral Lineage introduction in the country from the Caribbean.

Discussion {#s4}
==========

In the Americas, the first DENV-2 was isolated in 1953 in Trinidad [@pntd.0002095-Anderson1] and the first DHF epidemic caused by this serotype occurred in Cuba in 1981 after the introduction of DENV-2 genotype originated in Southeast Asia [@pntd.0002095-Guzman1], [@pntd.0002095-Kouri1]. Epidemics studies showed that the DENV-2 introduced in Brazil, Colombia, Venezuela and Mexico had a common ancestor with isolates from Southeast Asia, suggesting the direct transmission from that region to the Americas [@pntd.0002095-RicoHesse2].

In Brazil, the first DHF/DSS cases were reported after the DENV-2 introduction in Rio de Janeiro [@pntd.0002095-Nogueira1], [@pntd.0002095-Zagne1], [@pntd.0002095-Vasconcelos1], which spread to other states in the country. Phylogenetic analysis of DENV-2 strains circulating at that time confirmed the genotype circulating in Southeast Asia [@pntd.0002095-Miagostovich1], [@pntd.0002095-dosSantos1]. This observation was further corroborated in an extensive analysis of viruses from the states of Rio de Janeiro (1990 and 1995), Ceará (1994), Bahia (1994 and 1999), Maranhão (1996 and 1998), Mato Grosso (1997), Pará (1998), Rio Grande do Norte (1998), Paraíba (1999) Sergipe (1999), Espiríto Santo (1995 and 2000) and forty strains isolated in Pernambuco (1995--2002) [@pntd.0002095-PiresNeto1], [@pntd.0002095-Cordeiro1].

After seven years without activity in Brazil, DENV-2 re-emerged in April of 2007 in the state of Rio de Janeiro causing the more severe dengue epidemic in the country in 2008 [@pntd.0002095-Teixeira1], [@pntd.0002095-SVSMS2]. Phylogenetic analysis of DENV-2 circulating in 90\'s and after its re-emergence identified two distinct lineages within the Southeast Asian genotype [@pntd.0002095-Oliveira1].

In the present study, the analysis based on the sequencing of the C/prM/M/E genes (2,325 bp) from 25 DENV-2 Brazilian isolates divided those strains in two distinct groups, one formed by DENV-2 isolated from 1991 to 2003 and another with strains isolated from 2007 to 2010 following the re-emergence of this serotype in the country. Corroborating previous phylogeny [@pntd.0002095-Miagostovich1]--[@pntd.0002095-Cordeiro1] strains isolated from 1991to 2003 were classified as Southeast Asian genotype, Lineage I and presenting similarities with the Brazilian strain BR64022/98 and the strain Jamaica/83. However, the strains isolated between 2007 and 2010, showed higher similarity with the strain DR59/01, from the Dominican Republic, representing the Southeast Asian genotype, Lineage II, corroborating the analysis by Oliveira *et al* [@pntd.0002095-Oliveira1]. A study by Aquino *et al* [@pntd.0002095-Aquino1] demonstrated that DENV-2 strains from Paraguay could also be grouped into two distinct lineages within the Southeast Asian genotype and suggested the introduction of a new lineage possibly associated a serotype shift from DENV-3 to DENV-2, as observed in Brazil in 2007 and 2008 [@pntd.0002095-SVSMS2].

The absence of DENV-2 circulation in the years prior to its re-emergence and the high similarity observed between those viruses and the strain isolated in the Dominican Republic in 2001, suggests the introduction of a new lineage of DENV-2 causing the 2008 epidemic in Brazil. Romano *et al* [@pntd.0002095-Romano1] also demonstrated that DENV-2 strains isolated in Sao Paulo State in 2010 were in a monophyletic group with the strains circulating in Rio de Janeiro in 2007 and 2008 and that those were closely related to strains isolated in Cuba and Dominican Republic, with a small genetic distance, suggesting that this new lineage of DENV-2 re-emerged in of Brazil may have been imported the Caribbean. Although genetic variants of DENV have been implicated in disease severity in the past [@pntd.0002095-Rosen1], [@pntd.0002095-Gubler4], it was with the advance of evolutionary studies based on phylogenetic analysis combined to epidemiological data that genotypes within the distinct serotypes were associated with a greater or lesser disease severity [@pntd.0002095-RicoHesse1], [@pntd.0002095-RicoHesse3]--[@pntd.0002095-Messer2].

The strain isolated from a DHF case in 2000 (strain RJ/67922/2000) presented an exclusive substitution on prM~143~ (T→I) when compared to the other strains analyzed in this study. However, substitutions related to DHF/DSS cases were identified on prM~16~ and prM~81~ [@pntd.0002095-Pandey1].

Substitutions were found on the residues E~129~ (V→I) and E~131~ (L→Q), and these are related to the division of the Southeast Asian genotype in two distinct clades, corroborating the observations that amino acids on E~129~ and E~131~ are in critical markers for genetic classification of DENV [@pntd.0002095-Aquino1], [@pntd.0002095-Bennett1].

All 34 strains analyzed in this study presented an asparagine (N) on E~390~, previously characterized as a probable trigger for DHF detected in strains of Asian origin [@pntd.0002095-Leitmeyer2]. Mutations on the flaviviruses domain III of E protein can induce virulence or attenuation of the virus to escape from the immune system [@pntd.0002095-Snchez1], [@pntd.0002095-Lin1] and in this study, changes were observed throughout this domain (aa 297 to 394). The DHF case, which culminated in death (59382/1997) showed amino acid differences only in the E gene, but those differences were shared with other DF cases strains, when they were compared to the strain BR64022/98.

In this study, a substitution on prM~39~ was observed on the strain 0690/2008 isolated from a DHF case with a fatal outcome, on the strain 55769/1996 from a DF case and on the strain 0199/2010.. Catteau *et al* [@pntd.0002095-Catteau1] demonstrated that the intracellular production of M ectodomain of all four DENV serotypes of DENV induce apoptosis in host cells. The carboxy terminus of prM protein with nine amino acids (aa 32--40) of some flaviviruses was designated as Apopto M [@pntd.0002095-Catteau1] and appears to play an important role in inducing apoptosis and cytopathic effects [@pntd.0002095-Catteau1]--[@pntd.0002095-Xiao1].

Several changes were observed along the NS protein genes. Studies conducted by Yábar, [@pntd.0002095-Varas1] show that mutations in NS1 are related to the development of DHF/DSS cases when they were compared to patients with DF.

Despite the functional importance of mutations in NS genes remains unknown, future studies can elucidate their role in the emergence of strains and/or pathogenesis of the disease. It was not possible to correlate the role of Lineage II emergence with an increased severity of cases observed in the period between the years 2007--2010. Furthermore, the occurrence of secondary infection may have been the risk factor for the development of more severe cases.

In conclusion, this result shows a temporal circulation of genetically different viruses in Brazil probably due to the introduction of a new viral lineage from the Caribbean which lead to the re-emergence of this serotype after 2007. In 2007--2008, DENV-2 was responsible for most severe epidemic already described in the country, with 787,726 cases reported and 491 deaths [@pntd.0002095-SVSMS2]. Moreover, the Caribbean has been suggested as an important region for the circulation of DENV-2, importation and exportation of strains from and to Central America and South America [@pntd.0002095-Bennett1], [@pntd.0002095-Carrington1], [@pntd.0002095-McElroy1].

In the past 20 years, DENV-2 activity in Brazil has contributed significantly to changes in the disease morbidity and sudden age shift [@pntd.0002095-Teixeira1]. In dengue endemic countries, displacement of DENV serotypes, genotypes and lineages have been reported previously and have been associated with changes in the disease severity [@pntd.0002095-Messer2], [@pntd.0002095-Zhang1]--[@pntd.0002095-Yamanaka1]. This emphasizes the need of straightening virological surveillance to monitor the emergence or re-emergence of DENV strains with pathogenic potential to cause epidemics.
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